These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35150862)

  • 21. The Potential for Placental Activation of PPARγ to Improve the Angiogenic Profile in Preeclampsia.
    Grimaldi B; Kohan-Ghadr HR; Drewlo S
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia.
    Rahman RA; Murthi P; Singh H; Gurungsinghe S; Leaw B; Mockler JC; Lim R; Wallace EM
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.
    Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
    Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R505-21. PubMed ID: 27280428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol mitigates trophoblast and endothelial dysfunction partly via activation of nuclear factor erythroid 2-related factor-2.
    Gurusinghe S; Cox AG; Rahman R; Chan ST; Muljadi R; Singh H; Leaw B; Mockler JC; Marshall SA; Murthi P; Lim R; Wallace EM
    Placenta; 2017 Dec; 60():74-85. PubMed ID: 29208243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression.
    Gilbert JS; Babcock SA; Granger JP
    Hypertension; 2007 Dec; 50(6):1142-7. PubMed ID: 17923588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paeoniflorin alleviates endothelial dysfunction caused by overexpression of soluble fms-like tyrosine kinase 1 and soluble endoglin in preeclampsia via VEGFA upregulation.
    Zhang J; Hua W; Zhao X; Yang F; Guo T; Zhang J; Zheng X; Liang W
    Biosci Biotechnol Biochem; 2021 Mar; 85(4):814-823. PubMed ID: 33590855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
    Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
    Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors.
    Saleh L; Samantar R; Garrelds IM; van den Meiracker AH; Visser W; Danser AHJ
    Hypertension; 2017 Sep; 70(3):594-600. PubMed ID: 28716993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
    Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
    Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta.
    Ye L; Gratton A; Hannan NJ; Cannon P; Deo M; Palmer KR; Tong S; Kaitu'u-Lino TJ; Brownfoot FC
    Placenta; 2016 Dec; 48():110-118. PubMed ID: 27871461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
    Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
    Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
    Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
    Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expert review: preeclampsia Type I and Type II.
    Yagel S; Cohen SM; Admati I; Skarbianskis N; Solt I; Zeisel A; Beharier O; Goldman-Wohl D
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101203. PubMed ID: 37871693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sildenafil citrate on circulating levels of sFlt-1 in preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Cannon P; Nguyen V; Kaitu'u-Lino TJ
    Pregnancy Hypertens; 2018 Jul; 13():1-6. PubMed ID: 30177033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
    Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
    Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells.
    Eddy AC; Chapman H; Brown DT; George EM
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32039444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.